Patients with hemophilia A and inhibitors: prevention and evolving treatment paradigms
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2020.1739518
Abstract: ABSTRACT Introduction: Novel non-replacement therapies (e.g. emicizumab) have improved the management of patients with hemophilia A with and without inhibitors while introducing new challenges and increasing the complexity of clinical decision-making. Areas covered: Use of… read more here.
Keywords: patients hemophilia; inhibitor; use; inhibitors prevention ... See more keywords
The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
Sign Up to like & getrecommendations! Published in 2022 at "Antioxidants"
DOI: 10.3390/antiox11122500
Abstract: According to the 2021 report of the International Diabetes Federation (IDF), there have been approximately 573 million cases of type 2 diabetes mellitus (T2DM) among adults, which sets the disease as a major concern in… read more here.
Keywords: prevention treatment; sglt inhibitors; importance sglt; diabetic cardiomyopathy ... See more keywords